Molecular staging and the selection of therapy for non-small cell lung cancer.


Journal Article (Review)

The stage-specific selection of therapy is the standard for patients with non-small cell lung cancer. Investigation of the molecular biology of lung cancer has provided pathways and targets that may be used to improve the efficacy of therapy and improve the survival for patients with lung cancer.

Full Text

Duke Authors

Cited Authors

  • D'Amico, TA

Published Date

  • 2005

Published In

Volume / Issue

  • 17 / 3

Start / End Page

  • 180 - 185

PubMed ID

  • 16253819

Pubmed Central ID

  • 16253819

International Standard Serial Number (ISSN)

  • 1043-0679

Digital Object Identifier (DOI)

  • 10.1053/j.semtcvs.2005.06.011


  • eng

Conference Location

  • United States